3 ms·
There are multiple GLP-1 agonists on the market (five approved by the FDA for glycemic control, two of those also for weight loss) so I expect competition to dr
by pfdietz 2y ago
There are multiple GLP-1 agonists on the market (five approved by the FDA for glycemic control, two of those also for weight loss) so I expect competition to drive down prices.
- toomuchtodo 2y agoAn interesting fact is that as long as there is a shortage of a compound, pharmacies can make a version using compounding. If demand always outstrips supply, compounding will be permitted. https://kffhealthnews.org/news/article/glp1-compounding-pharmacies-wegovy-zepbound-copycat-drugs-shortages/ https://kffhealthnews.org/news/article/glp1-compounding-phar...